retatrutide trials weight loss (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works This weight-loss drug hasn't been

Type 2 diabetes is driven by a combination of insulin resistance, reduced insulin production over time, and excess glucose output from the liver

With insurance coverage (where available), copays can range from $25 to several hundred dollars depending on the plan

This type of vision loss is usually permanent, although approximately one-third of patients may experience some improvement, generally within the first six months, Dave said

2 This was a cohort study that analyzed administrative registers in Denmark from 2007 to 2021, Norway from 2010 to 2018, and Sweden from 2007 to 2021

If a product description includes spelling errors or terms such as compounded, generic version or same active ingredient as [brand name], it often indicates that the product is a compounded formulation

Nausea is the single most common side effect of GLP-1 receptor agonist medications and the most common reason patients in clinical trials and in clinic discontinue treatment